ICT: Focus on Surface Disinfection When Fighting COVID-19

Author: William A. Rutala, PhD, MPH, CIC and David J. Weber, MD, MPH

ICT-Article_Rutala_Weber_0320-2020
Categories: Articles March 20, 2020

Infection Control Today recently published an article written by William A. Rutala, PhD, MPH, CIC and David J. Weber, MD, MPH

Focus on Surface Disinfection When Fighting COVID-19

Source: ICT

Excerpt from article:

“Based on the EPA emerging viral pathogen criteria, an EPA-registered, hospital disinfectant must have a disinfectant efficacy claim against at least 1 small or 1 large non-enveloped virus to be eligible for use against an enveloped emerging viral pathogen.2 EPA’s List N identifies which registered products have this designation on their Master Label.³

Why does this matter? Over the past decade, there has been a growing appreciation that environmental contamination of hospital surfaces promotes infection transmission for many pathogens. Studies with epidemiologically important pathogens (e.g., MRSA, VRE, C. difficile) have shown that surfaces are contaminated and the frequency of hand contamination correlates to the frequency of environmental contamination.”

 

Read article